Other reports had suggested that YM155 exerts its anticancer effects independently of the cellular p53 status.26, 27, 28 However, the relevance of the p53 status for cancer cell sensitivity to YM155 and survivin depletion may depend on the cellular context. The gene discussed is BIRC5; the disease is cancer.